Antibody News and Research

RSS
An antibody is a blood protein that is produced in response to and counteracts an antigen. Antibodies are produced in response to disease and help the body fight against the particular disease. In this way, antibodies help the body develop an immunity to disease.

Further Reading

Nanoparticle method captures and measures common marker of heart disease

Nanoparticle method captures and measures common marker of heart disease

America’s obesity epidemic threatens effectiveness of any COVID vaccine

America’s obesity epidemic threatens effectiveness of any COVID vaccine

Cats susceptible to and potential reservoirs for novel coronavirus

Cats susceptible to and potential reservoirs for novel coronavirus

Evidence for antibody longevity in COVID-19 patients

Evidence for antibody longevity in COVID-19 patients

New serological test for COVID-19 helps determine herd immunity, vaccine efficacy

New serological test for COVID-19 helps determine herd immunity, vaccine efficacy

Beneficial microbes reprogram the B cell repertoire that produce antibodies

Beneficial microbes reprogram the B cell repertoire that produce antibodies

Study provides comprehensive update on ACE2 enzyme with key role in SARS-CoV-2 infection

Study provides comprehensive update on ACE2 enzyme with key role in SARS-CoV-2 infection

Avidity of binding responsible for cross-neutralization of SARS-CoV-1 and SARS-CoV-2

Avidity of binding responsible for cross-neutralization of SARS-CoV-1 and SARS-CoV-2

Potential antibody treatment for yellow fever developed in 7 months using Rapid Response Strategy

Potential antibody treatment for yellow fever developed in 7 months using Rapid Response Strategy

Regeneron's COVID-19 antibody-drug cocktail treats SARS-CoV-2 virus in animals

Regeneron's COVID-19 antibody-drug cocktail treats SARS-CoV-2 virus in animals

ACTG initiates novel clinical trial to evaluate multiple therapeutics for COVID-19

ACTG initiates novel clinical trial to evaluate multiple therapeutics for COVID-19

NIH trial to evaluate potential new therapeutics for mild, moderate COVID-19

NIH trial to evaluate potential new therapeutics for mild, moderate COVID-19

Picomolar inhibitors to SARS-CoV-2 proteins

Picomolar inhibitors to SARS-CoV-2 proteins

Test, trace, isolate key to safe schools in COVID-19

Test, trace, isolate key to safe schools in COVID-19

Regeneron antibody cocktail shows promise as potential COVID-19 treatment

Regeneron antibody cocktail shows promise as potential COVID-19 treatment

Clinical trial to test safety, efficacy of antibody treatment in hospitalized COVID-19 patients

Clinical trial to test safety, efficacy of antibody treatment in hospitalized COVID-19 patients

Five alternative methods of SARS-CoV-2 suppression

Five alternative methods of SARS-CoV-2 suppression

A new platform to provide information on SARS-CoV-2 immunity or seroprevalence

A new platform to provide information on SARS-CoV-2 immunity or seroprevalence

Study shows high SARS-CoV-2 seroprevalence, but low death rate in Malawi's health care workers

Study shows high SARS-CoV-2 seroprevalence, but low death rate in Malawi's health care workers

SARS-CoV-2 lured away and trapped by a new decoy version of ACE2

SARS-CoV-2 lured away and trapped by a new decoy version of ACE2